Startup Atom Daily cover art

Startup Atom Daily

Startup Atom Daily

By: Startup Atom
Listen for free

LIMITED TIME OFFER | £0.99/mo for the first 3 months

Premium Plus auto-renews at £8.99/mo after 3 months. Terms apply.

About this listen

Your daily dose of startup news your drive to office! Hear from successful entrepreneurs on actionable tips and strategies to stay on top of the game!© Startup Atom 2023 Politics & Government
Episodes
  • Feb 17, 2023 - Startup Atom Daily
    Feb 17 2023

    Today's News Podcast is a must-listen for anyone who wants to stay in the loop. Tesla recalls 362,758 vehicles over Full Self-Driving software safety concerns. Instagram launches a new broadcast chat feature called ‘Channels’. Lensa AI climbs the App Store charts as its ‘magic avatars’ go viral. Airtable, last valued at $11 billion for its no-code software, lays off over 250. NextKidney secures €11.9M to develop portable artificial kidney device.

    Show More Show Less
    5 mins
  • Feb 16, 2023 - Startup Atom Daily
    Feb 16 2023

    Today's News Podcast is a must-listen for anyone who wants to stay in the loop. MYFLEXBOX secures €75M for its open-access smart locker network. B2B mobility startup Transferz raises €6.5M; aims to become profitable in the next quarter. Paris-based Brigad raises €33M Series B led by Balderton Capital; looks for M&A opportunities in Europe. Tesla agrees to double supercharger network, open to all EVs under Biden’s $7.5B charging plan. You.com takes aim at Google and Microsoft with multimodal chat search.

    Show More Show Less
    6 mins
  • Feb 15, 2023 - Startup Atom Daily
    Feb 15 2023

    Today's News Podcast is a must-listen for anyone who wants to stay in the loop. Tesla workers in New York launch a union campaign. Airbnb posts a record Q4 as travel recovers post-pandemic. Tubi reaches 64M monthly active users as ad-supported streaming grows. Trace.Space raises €1.3M to help engineers develop complex products 10x faster. Evotec bags €150M loan from EIB to accelerate global access to therapeutics.

    Show More Show Less
    5 mins
No reviews yet